Related Experiment Video

Updated: Apr 22, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

Defective natural killer cell anti-viral capacity in paediatric HBV infection

I L Heiberg1, L J Pallett, T N Winther

  • 1Department of Paediatrics, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.

Clinical and Experimental Immunology
|October 15, 2014
PubMed

Insights

Natural killer (NK) cells show impaired interferon-gamma production in children with chronic hepatitis B virus (CHB) infection. This defect, seen early in childhood, suggests potential therapeutic timing for restoring immune control.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Natural killer (NK) cells have dysregulated function in adult chronic hepatitis B virus (CHB) infection, potentially contributing to viral persistence.
  • The role of NK cells in children with perinatal HBV infection is not well understood.

Purpose of the Study:

  • To evaluate NK cell frequency, phenotype, and function in children with CHB compared to uninfected children.
  • To understand the implications of NK cell defects in pediatric CHB for immune control.

Main Methods:

  • Cross-sectional evaluation of a unique cohort of HBV-infected children.
  • Analysis of NK cell frequency, phenotype (including NKp30 expression), and function (IFN-γ production and cytolytic activity).

Main Results:

  • A selective defect in NK cell interferon (IFN)-γ production was observed in children with CHB.
  • NK cell cytolytic function remained conserved, similar to findings in adult CHB.
  • Reduced NKp30 expression on NK cells suggests impaired NK-dendritic cell (DC) interactions may contribute to reduced IFN-γ production.

Conclusions:

  • NK cells are already functionally defective in pediatric CHB, though less severely than in adults.
  • Impaired NK-DC interactions might underlie the reduced IFN-γ production.
  • These findings have implications for the optimal timing of antiviral therapies to restore immune control in pediatric HBV infection.

Keywords:
IFN-γNK cellsNKp30anti-viral functionpaediatric HBV infection

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

2.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
87
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
391